95 patents currently held
119 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Of the 119 now held by other companies, 79 name Jiangsu Hecheng Display Technology Co. Ltd. as their current owner, and 40 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
22
Ending by 2030
Nov 2026
Next term end
88
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2029 · High confidence
Also notable
Ends Mar 2032 · Medium confidence
Also notable
Ends Apr 2031 · Low confidence
Platelet Aggregation Inducing Substance
US 8,686,117
Cited by 48 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Process for Producing Substituted Benzo[f]imidazo[1,2-a]quinoxalin-3(11h)-ones
US 8,975,403
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2032.
Coelenterazine Analogues and Coelenteramide Analogues
US 8,883,432
Granted 2014 and renewed at 2 of 3 maintenance windows. Protection runs to 2031.
Formerly held, still cited
Notable
Ends Jun 2035 · High confidence
The most cited patent in this portfolio, cited by 143 later US patents, top 1% of utility patents granted in 2019 in our data. Protection runs to 2035.
now held by SK Materials JNC Co., Ltd.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Dec 4 to 27, 2026 · next Dec 4
- 1 fee due Jan 9, 2027The maintenance fee for Liquid Crystal Device (US 10,344,212) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 2 fees due Feb 25 to 27, 2027 · next Feb 25
- 1 fee due Mar 3, 2027The maintenance fee for Analyte-Measuring Sensor (US 10,401,356) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 2 fees due Apr 6 to 30, 2027 · next Apr 6
- 2 fees due May 7 to 10, 2027 · next May 7
- 1 fee due Sep 15, 2027The maintenance fee for Chromatography Medium, Preparation Method of the Same, and Method for Producing Virus Vaccine Using the Chromatography Medium (US 9,283,542) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
- 2 fees due Oct 7 to 28, 2027 · next Oct 7
- 1 fee due Nov 3, 2027The maintenance fee for Hemostatic Material Containing Nano-Fiber Containing Synthetic Collagen (US 9,327,050) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
- 5 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 88 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,507,450 | Varnish for Forming Liquid Crystal Alignment Layer and Liquid Crystal Display Element Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 7,666,980 | Calcium-Binding Photoprotein, Gene Encoding the Same, and Use Thereof In force · High confidence | In force | High confidence | |
| US 7,888,087 | Fusion Protein of Fc-Binding Domain and Calcium-Binding Photoprotein, Gene Encoding the Same and Use Thereof In force · High confidence | In force | High confidence | |
| US 8,981,059 | Platelet Aggregation Inducing Substance In force · Medium confidence | In force | Medium confidence | |
| US 7,868,112 | Fluorine-Containing Polymer and Resin Composition In force · High confidence | In force | High confidence | |
| US 8,030,042 | Polyamino Acid Synthetase and Gene Encoding the Same In force · High confidence | In force | High confidence | |
| US 7,687,593 | Fluorinated Polymer and Polymer Composition In force · High confidence | In force | High confidence | |
| US 7,847,047 | Thermoresponsive Polymer and Production Method Thereof In force · High confidence | In force | High confidence | |
| US 8,686,117 | Platelet Aggregation Inducing Substance In force · High confidence | In force | High confidence | |
| US 7,976,728 | Aqueous Solution of Polymer Having Upper Critical Solution Temperature, Aqueous Dispersion of Particle Modified with the Polymer and Method of Storing the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 95: 119 patents in force now held by others · 613 patents ended · 31 applications pending · 234 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.